Company Details
  • Taizhou Volsen Chemical Co., Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Americas , Asia , East Europe , Europe , North Europe , Other Markets , West Europe , Worldwide
  • Exporter:91% - 100%
  • Certs:GS, CE, ISO9001, ISO14000
  • Description:443913-73-3,Crystalline Powder Vandetanib CAS 443913-73-3,Vandetanib Also Called ZD6474/ Caprelsa/ CH 33 CAS 443913-73-3
Taizhou Volsen Chemical Co., Ltd. 443913-73-3,Crystalline Powder Vandetanib CAS 443913-73-3,Vandetanib Also Called ZD6474/ Caprelsa/ CH 33 CAS 443913-73-3
Home > Products > Active Pharmaceutical Ingredients > Potent VEGFR2 Inhibitor of Vandetanib CAS 443913-73-3

Potent VEGFR2 Inhibitor of Vandetanib CAS 443913-73-3

Share to:  
    Payment Type: L/C,T/T
    Incoterm: FOB,CIF
    Min. Order: 1 Kilogram
    Delivery Time: 25 Days

Basic Info

Model No.: 443913-73-3

Grade Standard: Medicine Grade

State: Solid

Additional Info

Packaging: 25KGS/DRUM

Productivity: Custom Manufacturing

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: In stock

Product Description

Vandetanib CAS NUMBER is 443913-73-3 is a multi-target tyrosine kinase inhibitor, belongs to aniline quinazoline compounds, as known as "second generation IRESSA". It is the first approved mediastinal thyroid cancer treatment drug that is suitable for the treatment of unresectable, locally advanced or metastatic symptomatic or progressive medullary thyroid carcinoma. A randomized, placebo-controlled clinical trial showed that Vandetanib significantly delayed the progression of locally advanced or metastatic thyroid medullary carcinoma. The recommended daily dose is 300 mg and should be discontinued when the patient is resistant to the drug or can not tolerate its toxicity. According to a study published by the Journal of Clinical Oncology, Vandetanib can effectively prolong progression-free survival in patients with non-small cell lung cancer (NSCLC) compared with gefitinib, which has an inhibitory effect only on EGFR. In clinical trials if the patient progress or can not tolerate toxicity, allowing it changes the treatment program. The test results showed that the control rate of patients treated with gefitinib instead of vandetanib 443913-73-3 was 14%, compared with 32% for patients treated with vandetanib instead of gefitinib.

Vandetanib CAS 443913-73-3, also called ZD647, Zactima, Caprelsa and CH 331, is an important product in our company. Vandetanib CAS NO 443913-73-3 appearance crystalline solid is a broad spectrum, orally available, small molecule and multi target tyrosine kinase inhibitor including vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR). Vandetanib 443913-73-3 is soluble in methanol, DMSO (4 mg/ml at 25℃), water (<1 mg/ml at 25℃), and ethanol (<1 mg/ml at 25℃). We have large quantity in stock. And if you need ZD647, please contact us. We can offer best service and bottom price.


Thera Category: VEGFR2 Inhibitor

Cas No.: 443913-73-3

Synonym: VANDETANIB;4-Quinazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-;Vandetanib for research;4-(4-Bromo-2-fluoroanilino)-6-methoxy- 7-[(1-methylpiperidin-4-yl)methoxy]quinazoline;N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine;Zactima;ZD 6474;7-((4-aminocyclohexyl)methoxy)-N-(4-bromo-2-fluorophenyl)-6-methoxyquinazolin-4-amine

443913-73-3

Molecular Formula:C22H24BrFN4O2

Molecular Weight: 475.35

Specifications: Available on request

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Looking for ideal 443913-73-3 Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Crystalline Powder Vandetanib CAS 443913-73-3 are quality guaranteed. We are China Origin Factory of Vandetanib Also Called ZD6474/ Caprelsa/ CH 33 CAS 443913-73-3. If you have any question, please feel free to contact us.

Product Categories : Active Pharmaceutical Ingredients

Product Images
  • Potent VEGFR2 Inhibitor of Vandetanib CAS 443913-73-3
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2018 Taizhou Volsen Chemical Co., Ltd. All rights reserved.
Communicate with Supplier?Supplier
Amy Cheng Ms. Amy Cheng
What can I do for you?